Skip to main content
Caplight Logo









Eilean Therapeutics

Eilean Therapeutics

Private
Dover, DelawareHealthcare & Life Scienceshttps://eileanther.com

Last Round

Seed

Jul 30, 2020

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eilean Therapeutics operates in Healthcare & Life Sciences and is based in Dover, Delaware. Its latest recorded funding round was a Seed round in July 2020.

Eilean Therapeutics is a biopharmaceutical company that develops small molecule therapies targeting resistance mechanisms in hematologic and solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Eilean Therapeutics Comparables

Compare Eilean Therapeutics with similar companies based on industry and business-model similarity.

Eilean Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kurome Therapeutics
93%
Aptose Biosciences Inc.
79%
Curis Inc
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Eilean Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 30, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Eilean Therapeutics Investors

Notable investors and investment history

Eilean Therapeutics investors
InvestorRounds
OrbiMedSeed
Torrey Pines Investment LLCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 32% MoM.

  • Jul 25, 2026

    Monthly visitors increased 42% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Eilean Therapeutics Filings

Explore SEC and related filing metadata, where available.

Eilean Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Eilean Therapeutics's valuation, stock price, and market status.

Is Eilean Therapeutics a public or private company?

Eilean Therapeutics is a private company.

What is the current stock price of Eilean Therapeutics?

Eilean Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eilean Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Eilean Therapeutics worth (valuation)?

Valuation information for Eilean Therapeutics is not publicly available.

Can I buy Eilean Therapeutics stock?

Eilean Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Eilean Therapeutics's last funding round?

Eilean Therapeutics's most recent funding round was Seed on July 30, 2020.

Who are the main investors in Eilean Therapeutics?

Key investors in Eilean Therapeutics include OrbiMed, Torrey Pines Investment LLC.

Will Eilean Therapeutics IPO soon?

No public IPO plans have been announced for Eilean Therapeutics.

How can I track Eilean Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in Eilean Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersDover, Delaware
Employee Range3
Year Founded2022
Last FundingJul 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?